The cranial clamps market is expected to register a CAGR of 4.7% over the forecast period. The key contributors that are expected to drive the market are the increasing traumatic brain injuries and other disorders.
- According to the American Speech-Language-Hearing Association, in 2016, the prevalence of traumatic brain injury was accounted to be around 27 million cases, and the incidence rate was observed to be around 369 per 100,000 individuals.
- Awake craniotomy is a type of surgery that is performed to treat certain neurological conditions while the patients are awake and alert. Awake craniotomy is considered as one of the most important and effective cranial surgeries. Cranial fixation devices in such types of surgery play a crucial role.
- Therefore, the above-mentioned factors are expected to boost the cranial clamps market growth during the forecast period.
Key Market Trends
The Hospital Segment is Expected to Exhibit a Significant Market Growth
The hospital segment is expected to grow at a significant rate due to the increasing burden of neurological diseases and the presence of skilled professionals. According to the World Federation of Neurological Societies, in 2016, the density of neurosurgeons was found to be around 1.586 per 100,000 people. Furthermore, according to the World Stroke Organization, the prevalence of hemorrhagic stroke, in 2016, was found to be around 15.3 million, while the incidence of the same was recorded to be approximately 4.1 million, worldwide. Such a high prevalence of diseases increases the need for treatments involving cranial clamps. Therefore, the aforementioned factors are expected to propel the cranial clamps market growth.
North America is Expected to Hold a Significant Share during the Forecast Period
North America is expected to be a dominant region in the cranial clamps market, owing to the rising prevalence of neurological diseases such as brain stroke. According to the Parkinson’s Foundation, around 60,000 people in the United States are diagnosed with Parkinson's every year, and it is estimated that in 2020, around 1 million people would be suffering from it. Furthermore, according to the National Spinal Cord Injury Association, approximately 450,000 people suffer from spinal cord injuries in the United States. Most of the spinal cord injuries are treated through surgeries that require a proper fixation of the head to provide easy access for the surgeons to operate. Also, the presence of skilled professionals related to the treatment of these injuries is expected to contribute positively to the market. According to the World Federation of Neurosurgical Societies, in 2016, the density of neurosurgeons in the United States was found to be around 1.6 per 100,000 people. Such factors are expected to positively impact the cranial clamps market.
The key players that are expected to be dominant in the cranial clamps market are pro med instruments GmbH, Johnson & Johnson (Depuy Synthes), Aesculap Inc., Integra LifeSciences Corporation, IMRIS, Deerfield Imaging Inc., B. Braun Melsungen AG, Micromar, and Allen Medical.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Scope of the Study
4.2 Market Drivers
4.2.1 Rising Prevalence of Brain Injuries
4.2.2 Increasing Number of Spine-related Surgeries
4.3 Market Restraints
4.3.1 Complications Associated with Cranial Clamps
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.2 By End User
5.2.3 Other End Users
5.3.1 North America
18.104.22.168 United States
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
220.127.116.11 South Africa
18.104.22.168 Rest of Middle-East and Africa
5.3.5 South America
22.214.171.124 Rest of South America
6.1.1 Aesculap Inc.
6.1.2 Allen Medical
6.1.3 B. Braun Melsungen AG
6.1.4 Integra LifeSciences Corporation
6.1.5 IMRIS, Deerfield Imaging Inc.
6.1.6 Johnson & Johnson (Depuy Synthes)
6.1.8 pro med instruments GmbH
A selection of companies mentioned in this report includes:
- Aesculap Inc.
- Allen Medical
- B. Braun Melsungen AG
- Integra LifeSciences Corporation
- IMRIS, Deerfield Imaging Inc.
- Johnson & Johnson (Depuy Synthes)
- pro med instruments GmbH